Correlation Between Apogee Therapeutics, and Catalyst Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Apogee Therapeutics, and Catalyst Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apogee Therapeutics, and Catalyst Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apogee Therapeutics, Common and Catalyst Pharmaceuticals, you can compare the effects of market volatilities on Apogee Therapeutics, and Catalyst Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apogee Therapeutics, with a short position of Catalyst Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apogee Therapeutics, and Catalyst Pharmaceuticals.
Diversification Opportunities for Apogee Therapeutics, and Catalyst Pharmaceuticals
-0.14 | Correlation Coefficient |
Good diversification
The 3 months correlation between Apogee and Catalyst is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Apogee Therapeutics, Common and Catalyst Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Catalyst Pharmaceuticals and Apogee Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apogee Therapeutics, Common are associated (or correlated) with Catalyst Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Catalyst Pharmaceuticals has no effect on the direction of Apogee Therapeutics, i.e., Apogee Therapeutics, and Catalyst Pharmaceuticals go up and down completely randomly.
Pair Corralation between Apogee Therapeutics, and Catalyst Pharmaceuticals
Given the investment horizon of 90 days Apogee Therapeutics, Common is expected to generate 2.61 times more return on investment than Catalyst Pharmaceuticals. However, Apogee Therapeutics, is 2.61 times more volatile than Catalyst Pharmaceuticals. It trades about 0.1 of its potential returns per unit of risk. Catalyst Pharmaceuticals is currently generating about 0.06 per unit of risk. If you would invest 4,385 in Apogee Therapeutics, Common on September 25, 2024 and sell it today you would earn a total of 365.00 from holding Apogee Therapeutics, Common or generate 8.32% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Apogee Therapeutics, Common vs. Catalyst Pharmaceuticals
Performance |
Timeline |
Apogee Therapeutics, |
Catalyst Pharmaceuticals |
Apogee Therapeutics, and Catalyst Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Apogee Therapeutics, and Catalyst Pharmaceuticals
The main advantage of trading using opposite Apogee Therapeutics, and Catalyst Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apogee Therapeutics, position performs unexpectedly, Catalyst Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Catalyst Pharmaceuticals will offset losses from the drop in Catalyst Pharmaceuticals' long position.Apogee Therapeutics, vs. Univest Pennsylvania | Apogee Therapeutics, vs. Algoma Steel Group | Apogee Therapeutics, vs. Chiba Bank Ltd | Apogee Therapeutics, vs. CECO Environmental Corp |
Catalyst Pharmaceuticals vs. Fate Therapeutics | Catalyst Pharmaceuticals vs. Caribou Biosciences | Catalyst Pharmaceuticals vs. Arcus Biosciences | Catalyst Pharmaceuticals vs. Karyopharm Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Complementary Tools
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |